Biotech Calendar

JUNE 13 WEEK

INVITROGEN CORP. (Symbol: IVGN): $300 million of senior convertible notes due 2025 to price on June 14; price talk is for a yield of 2.75% to 3.25%, with an initial conversion premium of 27.5% to 32.5%; non-callable for six years, with puts in years six, 10, and 15; bookrunners UBS Investment Bank and Banc of America; $50 million greenshoe; proceeds to repay $124 million borrowed under a revolving line of credit with Bank of America NA and other outstanding debt.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.